Cis-urocanic acid inhibits SAPK/JNK signaling pathway in UV-B exposed human corneal epithelial cells in vitro

Molecular Vision

Volumn 17, Issue , 2011, Pages 2311-2317

  Jauhonen, Hanna Mari ^a   Kauppinen, Anu ^b   Paimela, Tuomas ^b   Laihia, Jarmo K ^c   Leino, Lasse ^c   Salminen, Antero ^a,b   Kaarniranta, Kai ^a,b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c BioCis Pharma Ltd   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN C FOS; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE; UROCANIC ACID;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA CELL; CORNEAL EPITHELIAL CELL; DRUG MECHANISM; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ULTRAVIOLET B RADIATION;

APOPTOSIS; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; EPITHELIUM, CORNEAL; GENE EXPRESSION REGULATION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; L-LACTATE DEHYDROGENASE; MAP KINASE SIGNALING SYSTEM; NF-KAPPA B; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-FOS; ULTRAVIOLET RAYS; UROCANIC ACID;

EID: 80053023914     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Cullen AP. Photokeratitis and other phototoxic effects on the cornea and conjunctiva. Int J Toxicol 2002; 21:455-64. [PMID: 12537642]
2. Dolin PJ, Johnson GJ. Solar ultraviolet radiation and ocular disease: a review of the epidemiological and experimental evidence. Ophthalmic Epidemiol 1994; 1:155-64. [PMID: 8790622]
3. Ren H, Wilson G. The effect of ultraviolet-B irradiation on the cell shedding rate of the corneal epithelium. Acta Ophthalmol (Copenh) 1994; 72:447-52. [PMID: 7825410]
4. Kitaichi N, Shimizu T, Yoshida K, Honda A, Yoshihisa Y, Kase S, Ohgami K, Norisugi O, Makino T, Nishihira J, Yamagishi S, Ohno S. Macrophage migration inhibitory factor ameliorates UV-induced photokeratitis in mice. Exp Eye Res 2008; 86:929-35. [PMID: 18436209]
5. Gray RH, Johnson GJ, Freedman A. Climatic droplet keratopathy. Surv Ophthalmol 1992; 36:241-53. [PMID: 1549808]
6. Menegay M, Lee D, Tabbara KF, Cafaro TA, Urrets-Zavalía JA, Serra HM, Bhattacharya SK. Proteomic analysis of climatic keratopathy droplets. Invest Ophthalmol Vis Sci 2008; 49:2829-37. [PMID: 18378572]
7. Kaji Y, Nagai R, Amano S, Takazawa Y, Fukayama M, Oshika T. Advanced glycation end product deposits in climatic droplet keratopathy. Br J Ophthalmol 2007; 91:85-8. [PMID: 16973666]
8. Kaji Y, Oshika T, Takazawa Y, Fukayama M, Fujii N. Immunohistochemical localisation of D-beta-aspartic acidcontaining proteins in climatic droplet keratopathy. Br J Ophthalmol 2009; 93:977-9. [PMID: 19276099]
9. Holopainen JM, Serra HM, Sánchez MC, Sorsa T, Zalentein WN, Barcelona PF, Moilanen JA, Tervahartiala T, Tervo TM, Cafaro TA, Virtanen I, Urrets-Zavalia EA, Bhattacharya SK, Urrets-Zavalia JA. Altered expression of matrix metalloproteinases and their tissue inhibitors as possible contributors to corneal droplet formation in climatic droplet keratopathy. Acta Ophthalmol. 2009 [PMID: 19276099]
10. Black AT, Gordon MK, Heck DE, Gallo MA, Laskin DL, Laskin JD. UVB light regulates expression of antioxidants and inflammatory mediators in human corneal epithelial cells. Biochem Pharmacol. 2011 [PMID: 21300015]
11. Lu L, Wang L, Shell B. UV-induced signaling pathways associated with corneal epithelial cell apoptosis. Invest Ophthalmol Vis Sci 2003; 44:5102-9. [PMID: 14638704]
12. Cooper SJ, Bowden GT. Ultraviolet B regulation of transcription factor families: roles of nuclear factor-kappa B (NF-kappaB) and activator protein-1 (AP-1) in UVB-induced skin carcinogenesis. Curr Cancer Drug Targets 2007; 7:325-34. [PMID: 17979627]
13. Lewis DA, Spandau DF. UVB activation of NF-kappaB in normal human keratinocytes occurs via a unique mechanism. Arch Dermatol Res 2007; 299:93-101. [PMID: 17256146]
14. Alexander G, Carlsen H, Blomhoff R. Corneal NF-kappaB activity is necessary for the retention of transparency in the cornea of UV-B-exposed transgenic reporter mice. Exp Eye Res 2006; 82:700-9. [PMID: 16289165]
15. Helenius M, Makelainen L, Salminen A. Attenuation of NFkappaB signaling response to UVB light during cellular senescence. Exp Cell Res 1999; 248:194-202. [PMID: 10094826]
16. Shaulian E. AP-1-The Jun proteins: Oncogenes or tumor suppressors in disguise? Cell Signal 2010; 22:894-9. [PMID: 20060892]
17. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001; 410:37-40. [PMID: 11242034]
18. Chen W, Bowden GT. Role of p38 mitogen-activated protein kinases in ultraviolet-B irradiation-induced activator protein 1 activation in human keratinocytes. Mol Carcinog 2000; 28:196-202. [PMID: 10972989]
19. Chen W, Borchers AH, Dong Z, Powell MB, Bowden GT. UVB irradiation-induced activator protein-1 activation correlates with increased c-fos gene expression in a human keratinocyte cell line. J Biol Chem 1998; 273:32176-81. [PMID: 9822695]
20. Chen W, Bowden GT. Activation of p38 MAP kinase and ERK are required for ultraviolet-B induced c-fos gene expression in human keratinocytes. Oncogene 1999; 18:7469-76. [PMID: 10602506]
21. Chen YR, Wang X, Templeton D, Davis RJ, Tan TH. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. J Biol Chem 1996; 271:31929-36. [PMID: 8943238]
22. Karin M, Gallagher E. From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life 2005; 57:283-95. [PMID: 16036612]
23. Wisdom R, Johnson RS, Moore C. c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J 1999; 18:188-97. [PMID: 9878062]
24. Assefa Z, Garmyn M, Bouillon R, Merlevede W, Vandenheede JR, Agostinis P. Differential stimulation of ERK and JNK activities by ultraviolet B irradiation and epidermal growth factor in human keratinocytes. J Invest Dermatol 1997; 108:886-91. [PMID: 9182816]
25. Dérijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994; 76:1025-37. [PMID: 8137421]
26. Hibi M, Lin A, Smeal T, Minden A, Karin M. Identification of an oncoprotein-and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 1993; 7:2135-48. [PMID: 8224842]
27. Morton S, Davis RJ, McLaren A, Cohen P. A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J 2003; 22:3876-86. [PMID: 12881422]
28. Hayakawa J, Depatie C, Ohmichi M, Mercola D. The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair. J Biol Chem 2003; 278:20582-92. [PMID: 12663670]
29. Musti AM, Treier M, Bohmann D. Reduced ubiquitindependent degradation of c-Jun after phosphorylation by MAP kinases. Science 1997; 275:400-2. [PMID: 8994040]
30. Fuchs SY, Dolan L, Davis RJ, Ronai Z. Phosphorylationdependent targeting of c-Jun ubiquitination by Jun N-kinase. Oncogene 1996; 13:1531-5. [PMID: 8875991]
31. Shaulian E, Schreiber M, Piu F, Beeche M, Wagner EF, Karin M. The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest. Cell 2000; 103:897-907. [PMID: 11136975]
32. Anzi S, Finkin S, Shaulian E. Transcriptional repression of c-Jun's E3 ubiquitin ligases contributes to c-Jun induction by UV. Cell Signal 2008; 20:862-71. [PMID: 18295447]
33. Gao M, Labuda T, Xia Y, Gallagher E, Fang D, Liu YC, Karin M. Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch. Science 2004; 306:271-5. [PMID: 15358865]
34. Gibbs NK, Tye J, Norval M. Recent advances in urocanic acid photochemistry, photobiology and photoimmunology. Photochem Photobiol Sci 2008; 7:655-67. [PMID: 18528548]
35. Prater MR, Blaylock BL, Holladay SD. Molecular mechanisms of cis-urocanic acid and permethrin-induced alterations in cutaneous immunity. Photodermatol Photoimmunol Photomed 2003; 19:287-94. [PMID: 14617103]
36. Lauerma AI, Aioi A, Maibach HI. Topical cis-urocanic acid suppresses both induction and elicitation of contact hypersensitivity in BALB/C mice. Acta Derm Venereol 1995; 75:272-5. [PMID: 8578946]
37. Hart PH, Grimbaldeston MA, Finlay-Jones JJ. Mast cells in UVB-induced immunosuppression. J Photochem Photobiol B 2000; 55:81-7. [PMID: 10942071]
38. el-Ghorr AA, Norval M. The effect of chronic treatment of mice with urocanic acid isomers. Photochem Photobiol 1997; 65:866-72. [PMID: 9155259]
39. Kivistö K, Punnonen K, Toppari J, Leino L. Urocanic acid suppresses the activation of human neutrophils in vitro. Inflammation 1996; 20:451-9. [PMID: 8894710]
40. Rinaldi M, Moroni P, Leino L, Laihia J, Paape MJ, Bannerman DD. Effect of cis-urocanic acid on bovine neutrophil generation of reactive oxygen species. J Dairy Sci 2006; 89:4188-201. [PMID: 17033005]
41. Guymer RH, Mandel TE. Urocanic acid as an immunosuppressant in allotransplantation in mice. Transplantation 1993; 55:36-43. [PMID: 8420062]
42. Filipec M, Letko E, Hasková Z, Jenícková D, Holler P, Jancárek A, Holán V. The effect of urocanic acid on graft rejection in an experimental model of orthotopic corneal transplantation in rabbits. Graefes Arch Clin Exp Ophthalmol 1998; 236:65-8. [PMID: 9457519]
43. Yarosh DB, Gettings SD, Alas LG, Kibitel JT, San RH, Wagner VO 3rd, McEwen GN Jr. The biological interaction of cisand trans-urocanic acid and DNA. Photodermatol Photoimmunol Photomed 1992; 9:121-6. [PMID: 1300140]
44. IJland SA, Noonan FP, Ceryak S, Steenvoorden DP, Bouscarel B, Hug D, Beijersbergen van Henegouwen GM, De Fabo EC. Urocanic acid does not photobind to DNA in mice irradiated with immunosuppressive doses of UVB. Photochem Photobiol 1998; 67:222-6. [PMID: 9487799]
45. Macve JC, Norval M. The effects of UV waveband and cisurocanic acid on tumour outgrowth in mice. Photochem Photobiol Sci 2002; 1:1006-11. [PMID: 12661599]
46. Beissert S, Rühlemann D, Mohammad T, Grabbe S, El-Ghorr A, Norval M, Morrison H, Granstein RD, Schwarz T. IL-12 prevents the inhibitory effects of cis-urocanic acid on tumor antigen presentation by Langerhans cells: implications for photocarcinogenesis. J Immunol 2001; 167:6232-8. [PMID: 11714785]
47. Viiri J, Jauhonen HM, Kauppinen A, Ryhänen T, Paimela T, Hyttinen J, Sorri I, Laihia JK, Leino L, Kaarniranta K. Cisurocanic acid suppresses UV-B-induced interleukin-6 and-8 secretion and cytotoxicity in human corneal and conjunctival epithelial cells in vitro. Mol Vis 2009; 15:1799-805. [PMID: 19753313]
48. Pimienta G, Ficarro SB, Gutierrez GJ, Bhoumik A, Peters EC, Ronai Z, Pascual J. Autophosphorylation properties of inactive and active JNK2. Cell Cycle 2007; 6:1762-71. [PMID: 17637567]
49. Nakano H, Nakajima A, Sakon-Komazawa S, Piao JH, Xue X, Okumura K. Reactive oxygen species mediate crosstalk between NF-kappaB and JNK. Cell Death Differ 2006; 13:730-7. [PMID: 16341124]
50. Papa S, Bubici C, Zazzeroni F, Pham CG, Kuntzen C, Knabb JR, Dean K, Franzoso G. The NF-kappaB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease. Cell Death Differ 2006; 13:712-29. [PMID: 16456579]
51. Zhang JY, Tao S, Kimmel R, Khavari PA. CDK4 regulation by TNFR1 and JNK is required for NF-kappaB-mediated epidermal growth control. J Cell Biol 2005; 168:561-6. [PMID: 15699216]
52. Liu J, Yang D, Minemoto Y, Leitges M, Rosner MR, Lin A. NF-kappaB is required for UV-induced JNK activation via induction of PKCdelta. Mol Cell 2006; 21:467-80. [PMID: 16483929]
53. Pflugfelder SC. Antiinflammatory therapy for dry eye. Am J Ophthalmol 2004; 137:337-42. [PMID: 14962426]
54. Matsui M, Tashiro T. Protective effect of urocanic acid eyedrops to the ocular inflammation induced by the ultraviolet radiation. Nippon Ganka Gakkai Zasshi 1967; 71:571-6. [PMID: 5624646]
55. Cook EB. Tear cytokines in acute and chronic ocular allergic inflammation. Curr Opin Allergy Clin Immunol 2004; 4:441-5. [PMID: 15349046]
56. Luo L, Li DQ, Doshi A, Farley W, Corrales RM, Pflugfelder SC. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci 2004; 45:4293-301. [PMID: 15557435]